Literature DB >> 4943607

Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials.

H A Dewar, M F Oliver.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4943607      PMCID: PMC1799699          DOI: 10.1136/bmj.4.5790.784

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  14 in total

1.  The clofibrate saga: a retrospective commentary.

Authors:  Michael Oliver
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

2.  Antidepressants and the developing nervous system.

Authors:  John B Warren
Journal:  Br J Clin Pharmacol       Date:  2012-01       Impact factor: 4.335

3.  Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate.

Authors:  J C Postlethwaite; J A Dormandy
Journal:  Ann Surg       Date:  1975-06       Impact factor: 12.969

4.  The importance of plasma fibrinogen in vascular surgery.

Authors:  J C Postlethwaite
Journal:  Ann R Coll Surg Engl       Date:  1976-11       Impact factor: 1.891

5.  Hyperlipidaemia and deafness: a preliminary survey.

Authors:  J B Booth
Journal:  Proc R Soc Med       Date:  1977-09

6.  Who is for cholesterol testing?

Authors: 
Journal:  BMJ       Date:  1989-07-15

7.  Cholesterol trials and mortality.

Authors:  John B Warren; Simon B Dimmitt; Hans G Stampfer
Journal:  Br J Clin Pharmacol       Date:  2016-05-02       Impact factor: 4.335

8.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

Authors: 
Journal:  Br Heart J       Date:  1978-10

Review 9.  Therapy of lipid disorders.

Authors:  D M Krikler
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1973

10.  Confusion with clofibrate.

Authors: 
Journal:  Br Med J       Date:  1972-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.